Yishay Pinto

Yishay Pinto

Auto-generated profile, based on publicly available information

Yishay Pinto

Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2021 in Science
Verified
Journal Article
Closed access
PDF file
DLDoron Levin
Doron Levin
NRNeta Raab
Neta Raab
YPYishay Pinto
Yishay Pinto
DRDaphna Rothschild
Daphna Rothschild
GZGal Zanir
Gal Zanir
ESEran Segal
Eran Segal
Animals in the wild are able to subsist on pathogen-infected and poisonous food and show immunity to various diseases. These may be due to their microbiota, yet we have a poor understanding of animal microbial diversity and function. We used metagenomics to analyze the gut microbiota of more than 180 species in the wild, covering diverse classes, feeding behaviors, geographies, and traits. Using de novo metagenome assembly, we constructed and functionally annotated a database of more than 5000 genomes, comprising 1209 bacterial species of which 75% are unknown. The microbial composition, diversity, and functional content exhibit associations with animal taxonomy, diet, activity, social structure, and life span. We identify the gut microbiota of wild animals as a largely untapped resource for the discovery of therapeutics and biotechnology applications.

10 January 2023 in Gut
Verified
Journal Article
Open access
PDF file
YPYishay Pinto
Yishay Pinto
SFSigal Frishman
Sigal Frishman
STSondra Turjeman
Sondra Turjeman
AEAdi Eshel
Adi Eshel
MNMeital Nuriel-Ohayon
Meital Nuriel-Ohayon
OKOmry Koren
Omry Koren
Objective Gestational diabetes mellitus (GDM) is a condition in which women without diabetes are diagnosed with glucose intolerance during pregnancy, typically in the second or third trimester. Early diagnosis, along with a better understanding of its pathophysiology during the first trimester of pregnancy, may be effective in reducing incidence and associated short-term and long-term morbidities. Design We comprehensively profiled the gut microbiome, metabolome, inflammatory cytokines, nutrition and clinical records of 394 women during the first trimester of pregnancy, before GDM diagnosis. We then built a model that can predict GDM onset weeks before it is typically diagnosed. Further, we demonstrated the role of the microbiome in disease using faecal microbiota transplant (FMT) of first trimester samples from pregnant women across three unique cohorts. Results We found elevated levels of proinflammatory cytokines in women who later developed GDM, decreased faecal short-chain fatty acids and altered microbiome. We next confirmed that differences in GDM-associated microbial composition during the first trimester drove inflammation and insulin resistance more than 10 weeks prior to GDM diagnosis using FMT experiments. Following these observations, we used a machine learning approach to predict GDM based on first trimester clinical, microbial and inflammatory markers with high accuracy. Conclusion GDM onset can be identified in the first trimester of pregnancy, earlier than currently accepted. Furthermore, the gut microbiome appears to play a role in inflammation-induced GDM pathogenesis, with interleukin-6 as a potential contributor to pathogenesis. Potential GDM markers, including microbiota, can serve as targets for early diagnostics and therapeutic intervention leading to prevention.

2 November 2025 in bioRxiv
Verified
Preprint
Open access
ACAntonio Pedro Camargo
Antonio Pedro Camargo
FBFotis Baltoumas
Fotis Baltoumas
ENEric Olo Ndela
Eric Olo Ndela
MFMateus B. Fiamenghi
Mateus B. Fiamenghi
BMBryan Merrill
Bryan Merrill
NKNikos C. Kyrpides
Nikos C. Kyrpides
Viruses are key modulators of human gut microbiome composition and function. While metagenomic sequencing has enabled culture-independent discovery of gut bacteriophage diversity, existing genomic catalogues suffer from limited geographic representation, sparse taxonomic classification, and insufficient functional annotation, hindering detailed investigation into phage biology. Here, we present the Unified Human Gastrointestinal Virome (UHGV), a collection of 873,994 viral genomes from globally diverse populations that addresses these limitations. UHGV provides high-quality virome references with extensive host predictions, comprehensive functional annotations, protein structures, a classification framework for comparative analysis, and a web portal to facilitate data access. Using UHGV to profile worldwide metagenomes, we found that host range breadth is strongly associated with phage prevalence. Additionally, we identified diversity-generating retroelements and DNA methyltransferases as key factors enabling phage populations to access diverse hosts, revealing how specific genomic features contribute to global phage distribution patterns. UHGV is available at http://uhgv.jgi.doe.gov.

5 January 2024 in Gut
Verified
Journal Article
Open access
PDF file
SFSigal Frishman
Sigal Frishman
MNMeital Nuriel-Ohayon
Meital Nuriel-Ohayon
STSondra Turjeman
Sondra Turjeman
YPYishay Pinto
Yishay Pinto
OYOr Yariv
Or Yariv
OKOmry Koren
Omry Koren

13 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SZSoumaya Zlitni
Soumaya Zlitni
SBSierra Bowden
Sierra Bowden
HSHila Sberro
Hila Sberro
MTMarcelo Der Torossian Torres
Marcelo Der Torossian Torres
JVJoan M Vaughan
Joan M Vaughan
ABAmi S. Bhatt
Ami S. Bhatt
Enterococcus faecalis is a resident of the human gut, though upon translocation to the blood or body tissues, it can be pathogenic. Here we discover and characterize two peptide-based quorum-sensing systems that transcriptionally modulate de novo purine biosynthesis in E. faecalis . Using a comparative genomic analysis, we find that most enterococcal species do not encode this system; E. moraviensis , E. haemoperoxidus and E. caccae , three species that are closely related to E. faecalis , encode one of the two systems, and only E. faecalis encodes both systems. We show that these systems are important for the intracellular survival of E. faecalis within macrophages and for the fitness of E. faecalis in a murine wound infection model. Taken together, we combine comparative genomics, microbiological, bacterial genetics, transcriptomics, targeted proteomics and animal model experiments to describe a paired quorum sensing mechanism that directly influences central metabolism and impacts the pathogenicity of E. faecalis .

5 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
YPYishay Pinto
Yishay Pinto
MCMeenakshi Chakraborty
Meenakshi Chakraborty
NJNavami Jain
Navami Jain
ABAmi S Bhatt
Ami S Bhatt
The human gut microbiome is a diverse ecosystem that encompasses multiple domains of life and plays a vital role in human health. Due to technical limitations, most microbiome studies have focused on gut prokaryotes, overlooking bacteriophages and other gut viruses. The most common method to profile viruses is to assemble shotgun metagenomic reads - often from virus-enriched samples - and identify viral genomes de novo . While valuable, this resource-intensive and reference-independent method has limited sensitivity. To overcome these drawbacks, we developed Phanta, which profiles human gut metagenomes in a virus-inclusive manner directly from short reads utilizing recently published catalogs of gut viral genomes. Phanta incorporates k -mer based classification tools and was developed with virus-specific properties in mind. Specifically, it includes optimizations considering viruses’ small genome size, sequence homology with prokaryotes, and interactions with other members of the gut microbial community. Based on simulations, the workflow is fast and accurate with respect to both prokaryotes and viruses, minimizing false positive species identification using a novel genome coverage-based strategy. When applied to metagenomes from healthy adults, Phanta identified ~200 viral species per sample, ~5x more than the standard assembly-based methods. Notably, we observed a 2:1 ratio between gut viruses and bacteria, with higher interindividual variability of the gut virome compared to the gut bacteriome. Phanta performs equally well on bulk vs. virus-enriched metagenomes, making it possible to study prokaryotes and viruses in a single experiment, with a single analysis. Phanta can tandemly profile gut viruses and prokaryotes in existing and novel datasets, and can therefore identify cross-domain interactions with likely relevance to human health. We expect that Phanta will reduce the barrier to virus-inclusive studies of the human gut microbiome, thus making it standard practice.